United States Patent and Trademark Office
Home
|
Site Index
|
Search
|
Guides
|
Contacts
|
e
Business
|
eBiz alerts
|
News
|
Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0
Summary
Query:
Party Name contains all words: AFAXYS, INC.
Number of results:
7
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
91276166
05/12/2022
Voodoo Health Suppliments, LLC
Mark:
VALIBRA
S#:
90795057
Afaxys, Inc.
Mark:
VYLIBRA
S#:
86952102
R#:
5498300
91247481
04/09/2019
Afaxys, Inc.
Mark:
TULANA
S#:
87777573
Administrators of Tulane Educational Fund
Mark:
TULANE HOSPITAL FOR CHILDREN
S#:
74565301
R#:
1915719
Mark:
TULANE
S#:
76150900
R#:
2737647
Mark:
TULANE
S#:
76150901
R#:
2778223
Mark:
TULANE
S#:
76150902
R#:
2778224
Mark:
TULANE
S#:
76150903
R#:
2743096
Mark:
TULANE
S#:
76260290
R#:
2778298
Mark:
TU TULANE UNIVERSITY
S#:
78181385
R#:
2968179
Mark:
TULANE
S#:
78227016
R#:
3344941
Mark:
TULANE
S#:
78227306
R#:
3344946
Mark:
TULANE
S#:
78227332
R#:
3344947
Mark:
TULANE
S#:
78227528
R#:
3344949
Mark:
TULANE
S#:
78227620
R#:
3344950
Mark:
TU TULANE UNIVERSITY
S#:
78227636
R#:
3525631
Mark:
TULANE
S#:
78228374
R#:
3298668
Mark:
TULANE EMPOWERS
S#:
85846784
R#:
4403294
Mark:
TULANE EMPOWERS
S#:
85846861
R#:
4403306
Mark:
TULANE EMPOWERS HELPING PEOPLE BUILD A BETTER WORLD
S#:
85846885
R#:
4403310
Mark:
FLEUR DE LING: TULANE UNIVERSITY WORKING PAPERS
S#:
86153672
R#:
4752733
Mark:
TULANE
S#:
87528607
R#:
5395786
Mark:
TULANE
S#:
87649728
R#:
5475092
87777573
01/07/2019
Afaxys, Inc.
Mark:
TULANA
S#:
87777573
Administrators of Tulane Educational Fund
87804364
09/18/2018
Afaxys, Inc.
Mark:
ECONTRA ONE-STEP
S#:
87804364
Foundation Consumer Healthcare, LLC
85879467
08/16/2013
Afaxys, Inc.
Mark:
LYZA
S#:
85879467
Bristol-Myers Squibb Company
85879465
07/30/2013
Afaxys, Inc.
Mark:
ILANIA
S#:
85879465
Novartis AG
85726609
03/04/2013
Afaxys, Inc.
Mark:
AFAXYS
S#:
85726609
Abraxis Bioscience LLC
Results as of 11/21/2024 02:41 PM
Search again
|
.
HOME
|
INDEX
|
SEARCH
|
e
BUSINESS
|
CONTACT US
|
PRIVACY POLICY